a2 Milk has come out swinging in the first half of FY25, delivering double-digit revenue growth, an upgraded full-year outlook, and a historic first dividend for shareholders. The company is…
Imugene’s CD19 CAR-T Therapy Azer-cel Shows 57% Complete Response Rate in Phase 1b Trial
Imugene Limited (ASX: IMU) has reported more positive results from its Phase 1b clinical trial of azer-cel, an allogeneic off-the-shelf CD19 CAR-T therapy, for relapsed/refractory diffuse large B-cell lymphoma (DLBCL)….
Infomedia Takes a Bold Step into Automotive AI with Intellegam Acquisition
Infomedia Ltd (ASX: IFM) is accelerating its AI-powered future, announcing a 50% acquisition of Intellegam GmbH, a European automotive AI startup, for €6.1 million. This move strengthens Infomedia’s innovation agenda,…
Cochlear Delivers Steady Growth with Strong Implant Sales, Eyes New Product Launches
Cochlear Limited (ASX: COH) has wrapped up the first half of FY25 with solid revenue growth, fueled by demand for its cochlear and acoustic implants. However, a slowdown in Services…
Artrya Secures $15M to Fast-Track AI-Driven Coronary Disease Tech
Artrya Limited (ASX: AYA) has locked in $15 million through a two-tranche placement at $0.73 per share, raising funds to accelerate regulatory approvals, commercial adoption, and clinical studies for its…
AMP’s FY24 Results: Strong Growth in Wealth, Challenges in Banking
AMP (ASX: AMP) has posted a solid set of numbers for FY24, with a 15.1% rise in underlying NPAT to $236 million. The wealth management side of the business drove…
Winsome Resources Strengthens Critical Minerals Portfolio with High-Grade Cesium and Lithium Discoveries
Winsome Resources (ASX: WR1) continues to solidify its position in the critical minerals space, making significant strides in both its Power Metals Corp. (PWM) investment and its Sirmac-Clapier lithium-cesium discovery….
Temple & Webster Delivers Record Half-Year Results Amid Market Challenges
Temple & Webster (ASX: TPW) has once again delivered record-breaking results, with revenue surging 24% to $314 million for the half-year ending December 2024. Despite ongoing economic headwinds, the company…
Pro Medicus Delivers Record Half-Year Profit as North American Expansion Pays Off
Leading health imaging company Pro Medicus Limited (ASX: PME) has reported a record half-year profit of $51.7 million, up 42.7% from the previous period, as its footprint in North America…
Origin Energy’s Half-Year Profit Climbs to $1.02 Billion, Dividend Raised
Origin Energy (ASX: ORG) has posted a solid first-half performance, with statutory profit rising to $1.02 billion, up from $995 million a year earlier. Underlying profit also saw a significant…